A CENTRAL West hospital has been announced as the first site in the state to start participating in a clinical trial to investigate the effectiveness of treating cancer side effects with cannabis medicines. The Cannabinoids for Symptom Control in Advanced Cancer, an Open Label Prospective Clinical Trial in NSW (CARE NSW) began recruiting patients in February 2020 to see if the drug could provide a safe and effective new treatment option. The Western NSW Local Health District announced on Tuesday that Orange-based oncologist Dr Robert Zielinski would oversee the trial at Orange Hospital. The purpose of which is to try and determine the best dose and frequency of medicinal cannabis for reliving key symptoms of
